Skip to content
10-Q

Quarterly Report

CHINA SHENGHUO PHARMACEUTICAL HOLDINGS INC

0001354488-12-002964

← back to feed
Filed
May 30, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 29, 2012 19.68M sh
Capex Q1 2012 · Mar 31, 2012 $664.38K
Capex Q1 2012 · Mar 31, 2011 $2.29M
Operating Cash Flow Q1 2012 · Mar 31, 2012 $896.97K
Operating Cash Flow Q1 2012 · Mar 31, 2011 $2.61M
Short Term Debt Q1 2012 · Mar 31, 2012 $21.39M
Short Term Debt Q1 2012 · Dec 31, 2011 $15.86M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $6.68M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $1.25M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $1.41M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $1.67M
Stockholders Equity Q1 2012 · Mar 31, 2012 $1.68M
Stockholders Equity Q1 2012 · Dec 31, 2011 $2.12M
Current Liabilities Q1 2012 · Mar 31, 2012 $61.36M
Current Liabilities Q1 2012 · Dec 31, 2011 $52.8M
Current Assets Q1 2012 · Mar 31, 2012 $37.39M
Current Assets Q1 2012 · Dec 31, 2011 $29.61M
Total Assets Q1 2012 · Mar 31, 2012 $66.11M
Total Assets Q1 2012 · Dec 31, 2011 $58.31M
Sga Expense Q1 2012 · Mar 31, 2012 $1.38M
Sga Expense Q1 2012 · Mar 31, 2011 $1.03M
Rd Expense Q1 2012 · Mar 31, 2012 $231.95K
Rd Expense Q1 2012 · Mar 31, 2011 $121.73K
Net Income Q1 2012 · Mar 31, 2012 −$444.38K
Net Income Q1 2012 · Mar 31, 2011 $99.37K
Operating Income Q1 2012 · Mar 31, 2012 −$75.27K
Operating Income Q1 2012 · Mar 31, 2011 $407.56K
Gross Profit Q1 2012 · Mar 31, 2012 $6.7M
Gross Profit Q1 2012 · Mar 31, 2011 $5.64M
Cost Of Revenue Q1 2012 · Mar 31, 2012 $4.67M
Cost Of Revenue Q1 2012 · Mar 31, 2011 $3.81M
Revenue Q1 2012 · Mar 31, 2012 $11.37M
Revenue Q1 2012 · Mar 31, 2011 $9.44M